Inventor · disambiguated record
Fang Hu
Also filed as: HU FANG · Hu fang yuan
10 granted patents·9 pending applications·1 citations·filing 2001–2023
77Inventor score
Files withHANGZHOU CONVERD CO LTD11HU FANG2SHANGHAI SUNWAY BIOTECH CO LTD2BEIJING BEST LIFE REGENERATIVE MEDICINE TECH CO LTD1HANGZHOU VIROMAB BIOTECH CO LTD1
Top patents by PatentIndex Score
19 records- 0167US2024100106A1Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancersHANGZHOU CONVERD CO LTD·Filed 2023·Application pending·0 cites
- 0266US2022339220A1Therapeutic agents comprising oncolytic vaccinia viruses and nk cells, and uses thereof for drugs for treatment of tumors and/or cancersHANGZHOU CONVERD CO LTD·Filed 2022·Application pending·0 cites
- 0365US10980859B2In vivo individualized systemic immunotherapeutic method and deviceHANGZHOU CONVERD CO LTD·Filed 2016·Granted Apr 20, 2021·1 cites·9 claims
- 0462US12329826B2Therapeutic agents comprising nucleic acids and CAR-modified immune cells, and uses thereofHANGZHOU CONVERD CO LTD·Filed 2019·Granted Jun 17, 2025·0 cites·17 claims
- 0561US2025213440A1Gel hand sanitizer and preparation method thereforSOLVENTUM INTELLECTUAL PROPERTIES COMPANY·Filed 2022·Application pending·0 cites
- 0660US11819519B2Therapeutic agents comprising nucleic acids and TCR modified immune cells and uses thereofHANGZHOU CONVERD CO LTD·Filed 2019·Granted Nov 21, 2023·0 cites·15 claims
- 0760US11806374B2Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancersHANGZHOU CONVERD CO LTD·Filed 2018·Granted Nov 7, 2023·0 cites·26 claims
- 0860US11446345B2Therapeutic agents and uses thereof for drugs for treatment of tumors and/or cancersHANGZHOU CONVERD CO LTD·Filed 2018·Granted Sep 20, 2022·0 cites·15 claims
- 0958US2025304690A1Therapeutic agent comprising multispecific antibody and use thereof in tumor therapyHANGZHOU VIROMAB BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1056US2023265396A1Isolated recombinant oncolytic poxvirus capable of being regulated and controlled by microrna and use thereofHANGZHOU CONVERD CO LTD·Filed 2021·Application pending·0 cites
- 1154US2009053186A1Therapy for primary and metastatic cancersSHANGHAI SUNWAY BIOTECH CO LTD·Filed 2008·Application pending·0 cites
- 1253US11786552B2Therapeutic compositions and applications that comprise nucleic acids and adoptively transferred immune cellHANGZHOU CONVERD CO LTD·Filed 2020·Granted Oct 17, 2023·0 cites·13 claims
- 1349US2004202663A1Therapy for primary and metastatic cancersSHANGHAI SUNWAY BIOTECH CO LTD·Filed 2004·Application pending·0 cites
- 1445US10828397B2Regenerative medical material, preparation method therefor, and use thereofHU FANG·Filed 2016·Granted Nov 10, 2020·0 cites·12 claims
- 1544US11475798B2Simulation device for characterizing aerodynamics of dry power inhalants in respiratory systemZHUHAI RESPROLY PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Oct 18, 2022·0 cites·7 claims
- 1643US2020289591A1Isolated Recombinant Oncolytic Poxvirus, Pharmaceutical Composition, and Use Thereof in Treatment of Tumors and/or CancerHANGZHOU CONVERD CO LTD·Filed 2018·Application pending·0 cites
- 1741US11357804B2Application of oncolytic viruses as immunostimulants for treatment of tumors and/or cancersHANGZHOU CONVERD CO LTD·Filed 2018·Granted Jun 14, 2022·0 cites·5 claims
- 1836US2004146488A1Oncolytic microorganisms expressing hsp and uses thereofHU FANG·Filed 2001·Application pending·0 cites
- 1933US12343453B2Degradable regenerative medical material for promoting tissue in-situ regeneration and preparation method thereforBEIJING BEST LIFE REGENERATIVE MEDICINE TECH CO LTD·Filed 2019·Granted Jul 1, 2025·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Fang Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →